학술논문

AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
Document Type
Article
Source
In: The Lancet Gastroenterology and Hepatology. (The Lancet Gastroenterology and Hepatology, July 2022, 7(7):648-657)
Subject
Language
English
ISSN
24681253